Brokerages Set Definitive Healthcare Corp. (NASDAQ:DH) Target Price at $11.31

Definitive Healthcare Corp. (NASDAQ:DH) has been assigned an average recommendation of “Hold” from the nine research firms that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $11.31.

Several equities research analysts have commented on DH shares. Barclays boosted their price target on shares of Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research report on Friday, March 1st. Canaccord Genuity Group boosted their price target on shares of Definitive Healthcare from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 29th. Canaccord Genuity Group cut shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research report on Friday, January 5th. Stifel Nicolaus cut their price objective on Definitive Healthcare from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Wednesday, January 17th. Finally, Needham & Company LLC lowered shares of Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, January 17th.

Institutional Trading of Definitive Healthcare

A number of hedge funds have recently made changes to their positions in DH. Global Retirement Partners LLC lifted its position in shares of Definitive Healthcare by 86.0% in the third quarter. Global Retirement Partners LLC now owns 4,171 shares of the company’s stock worth $31,000 after purchasing an additional 1,928 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in shares of Definitive Healthcare by 599.6% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,786 shares of the company’s stock worth $58,000 after purchasing an additional 4,959 shares in the last quarter. Norden Group LLC purchased a new stake in shares of Definitive Healthcare in the first quarter worth approximately $83,000. Berry Wealth Group LP acquired a new position in Definitive Healthcare in the first quarter worth approximately $99,000. Finally, SG Americas Securities LLC acquired a new position in Definitive Healthcare in the third quarter worth approximately $116,000. 98.67% of the stock is owned by hedge funds and other institutional investors.

Definitive Healthcare Stock Performance

DH stock opened at $6.73 on Tuesday. The company has a market capitalization of $792.73 million, a P/E ratio of -3.78, a PEG ratio of 6.33 and a beta of 1.39. The company has a 50-day simple moving average of $8.16 and a 200 day simple moving average of $8.29. Definitive Healthcare has a fifty-two week low of $5.53 and a fifty-two week high of $12.45. The company has a quick ratio of 2.31, a current ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.01 by ($0.02). Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. The business had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Sell-side analysts predict that Definitive Healthcare will post 0.11 earnings per share for the current fiscal year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.